Collection 

Depression, suicidality and suicide prevention

Submission status
Open
Submission deadline

Up to 20% of individuals around the globe will suffer from depression in their lifetime; however, strategies to minimize risk and rapid treatments are not available for all affected individuals. Depression is a significant public health concern that impacts social and occupational functioning, and is also a major risk factor for suicide. Suicidal ideation and behaviour, for example, are often increased in individuals suffering from depression. Importantly, however, suicides are preventable when warning signs are recognized early, and timely, evidence-based interventions are implemented. The most successful efforts to prevent suicides are likely to be multipronged approaches that target different facets of experience to support at-risk individuals. This Collection welcomes original research articles that expand our understanding of depression and suicidality, which may or may not co-occur with depression. Studies reporting empirical research on the risk factors, warning signs, and strategies aimed at the prevention of suicide that may lead to policy recommendations are of particular interest.

Submit manuscript
Submission guidelines
Manuscript editing services
Helping hands

Editors

  • Chong Chen

    Yamaguchi University, Japan

  • Hsi-Chung Chen

    Division of Psychosomatic Medicine, Department of Psychiatry, National Taiwan University Hospital, Taiwan

  • Irina Esterlis

    Yale University Departments of Psychiatry and Psychology, and VA NCPTSD, USA

  • Roger C.M. Ho

    Professor and Senior Consultant Psychiatrist, Department of Psychological Medicine and Institute for Health Innovation and Technology (iHealthtech), National University of Singapore, Singapore

Chong Chen is an Assistant Professor at Yamaguchi University, Japan. His research aims to elucidate the underlying mechanisms and risk factors of neuropsychiatric diseases, while also focusing on the development of efficient and potent intervention strategies. Dr Chen has been an Editorial Board Member for Scientific Reports since 2022.

 

 

Hsi-Chung Chen is a researcher at the Department of Psychiatry, National Taiwan University Hospital, Taiwan. Their research interests include studies of psychosomatic medicine, establishment and translation of psychometric instruments, analysing continuous physiological signals with power spectral approach, and identifying neurophysiological markers of various psychiatric disorders. They are also interested in tackling the heterogeneity of major depressive disorder to enable precise medicine. Dr. Chen has been an Editorial Board Member for Scientific Reports since 2022.

 

Irina Esterlis is a Neuropsychologist and PET imager, and Associate Professor with Tenure in the Departments of Psychiatry and Psychology at Yale University. Dr. Esterlis’ work focuses on identifying neurochemical markers to help diagnose and treat disorders such as unipolar and bipolar depression and post traumatic stress disorder, as well as identifying endophenotypes of suicidality. Dr. Esterlis has been an Editorial Board Member for Scientific Reports since 2023.

 

 

Roger Ho is a Professor and Senior Consultant Psychiatrist at the department of Psychological Medicine and Institute for Health Innovation and Technology, National University of Singapore. He has clinical and research interests in applying functional near infrared spectroscopy (fNIRS) in diagnosing psychiatric disorders including attention deficit and hyperactivity disorder (ADHD), borderline personality disorder, major depressive disorder and dementia. Professor Ho has been an Editorial Board Member for Scientific Reports since 2022.